Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00194714
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2005-09-13
Brief Title:
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Ovarian Cancer |
| HER2Neu Positive |
| HLA-A2 Positive Cells Present |
| Stage IV Breast Cancer |
Keywords: